Pituitary tumour types in dogs and cats.
Sanders K, Galac S, Meij BP.
Vet J. 2021 Apr;270:105623. doi: 10.1016/j.tvjl.2021.105623. Epub 2021 Jan 25.
Nonfunctioning Pituitary Lesions.
Brownlee BP, Mann D, Glenn C, McKinney KA.
Otolaryngol Clin North Am. 2022 Apr;55(2):343-350. doi: 10.1016/j.otc.2021.12.015.
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas.
Nf L, Ai M.
Pituitary. 2023 Apr;26(2):182-186. doi: 10.1007/s11102-023-01312-9. Epub 2023 Apr 29.
How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.
Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C.
Cancers (Basel). 2020 Feb 22;12(2):514. doi: 10.3390/cancers12020514.
The molecular biology of thyrotroph pituitary neuroendocrine tumors.
Horiguchi K.
Endocr J. 2023 Feb 28;70(2):135-139. doi: 10.1507/endocrj.EJ22-0514. Epub 2023 Jan 19.
Thyrotropin pituitary adenomas.
de Angelis M, Cappabianca P.
World Neurosurg. 2014 Dec;82(6):1026-7. doi: 10.1016/j.wneu.2014.06.037. Epub 2014 Jun 18.
Coexistence of corticotroph adenoma and thyrotroph hyperplasia in a dog.
Teshima T, Hara Y, Shigihara K, Takekoshi S, Nezu Y, Harada Y, Yogo T, Teramoto A, Osamura RY, Tagawa M.
J Vet Med Sci. 2009 Jan;71(1):93-8. doi: 10.1292/jvms.71.93.
Somatostatin receptor profile in pituitary thyrotroph adenomas.
Thodou E, Kontogeorgos G.
Clin Neurol Neurosurg. 2020 Aug;195:105865. doi: 10.1016/j.clineuro.2020.105865. Epub 2020 Apr 22.
Molecular Biology of Pituitary Adenomas.
Faltermeier CM, Magill ST, Blevins LS Jr, Aghi MK.
Neurosurg Clin N Am. 2019 Oct;30(4):391-400. doi: 10.1016/j.nec.2019.05.001. Epub 2019 Jul 5.
Pituitary hyperplasia.
Horvath E, Kovacs K, Scheithauer BW.
Pituitary. 1999 May;1(3-4):169-79. doi: 10.1023/a:1009952930425.
